Source comparison
Best SS-31 Dosage for Aging: Protocol Comparison
Low-dose maintenance 0.25mg/kg Twice daily Subcutaneous ~85% 8-10 hours per dose Healthspan extension in young-to-middle-aged models Standard therapeutic 0.5-1mg/kg Aging mitochondrial dysfunction, cardiovascular models High-dose intervention 3mg/kg Once daily
This comparison does not assign a generated winner or score.
- Low-dose maintenance
- 0.25mg/kg
- Twice daily
- Subcutaneous
- ~85%
- 8-10 hours per dose
- Healthspan extension in young-to-middle-aged models
- Standard therapeutic
- 0.5-1mg/kg
- Aging mitochondrial dysfunction, cardiovascular models
- High-dose intervention
- 3mg/kg
- Once daily
- Intravenous
- ~95%
- 10-12 hours
- Acute mitochondrial injury, ischemia-reperfusion studies
- Oral (not recommended)
- 5-10mg/kg
- Oral
- 2-5%
- Minimal
- Poor bioavailability makes this ineffective for aging protocols